Rubicon Research Ltd.
Issue Open Date 09-Oct-25  
Issue Closing Date 13-Oct-25  
Application Money 100  
Allotment Money  
Price Band () 461 - 485  
Minimum Bid Quantity. 30  
Issue Size (Shares) 16455670  
Market Lot 1  
Objective

1. Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by our Company2. Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes

Business Description

We are a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets and in particular the United States. Based on the peer set (of six listed Indian companies assessed by F&S, and our Company), we are the only Indian pharmaceutical player w...

Promoter's Holding
Total Share Capital   120407506  
Offered to Public   16455670  
Promoter's Holding (Pre-Issue)   77.97  
Promoter's Holding (Post-Issue)   59.99  
Address
Address :Medone House
B-75
Road No. 33
Wagle Estate
Thane (West)
City :Thane, State :Maharashtra Pincode :400604 Phone :022- 61414000 Email : secretarial@rubicon.co.in Website : www.rubicon.co.in
Registrar
MUFG Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
BSE, NSE
Lead Manager
Axis Capital Ltd.
IIFL Securities Ltd.
JM Financial Ltd.
SBI Capital Markets Ltd
Promoters
General Atlantic Singapore RR Pte. Ltd.
Parag Suganchand Sancheti
Pratibha Pilgaonkar
Sudhir Dhirendra Pilgaonkar
Sumant Sudhir Pilgaonkar
Surabhi Parag Sancheti

© 2019. MSE Financial Services Ltd. All Rights Reserved

Developed & Content Powered by  Accord Fintech Pvt. Ltd.